State Key Laboratory of Toxicology and Medical Countermeasures, and Laboratory of Toxicant Analysis, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China
*: Lei Guo, Email: guolei@bmi.ac.cn;
Jian-Wei Xie, Email: xiejw@bmi.ac.cn
纸质出版:2015-03
Scan QR Code
The roles of carboxylesterase and CYP isozymes on the
Ni-ni Lin, Jia Chen, Bin Xu, et al. The roles of carboxylesterase and CYP isozymes on the
Background:
2
T-2 toxin poses a great threat to human health because it has the highest toxicity of the currently known trichothecene mycotoxins. To understand the in vivo toxicity and transformation mechanism of T-2 toxin
we investigated the role of two principal phase Ⅰ drug-metabolizing enzymes (cytochrome P450 [CYP450] enzymes) on the metabolism of T-2 toxin
which are crucial to the metabolism of endogenous substances and xenobiotics. We also investigated carboxylesterase
which also plays an important role in the metabolism of toxic substances.
Methods:
2
A chemical inhibition method and a recombinant method were employed to investigate the metabolism of the T-2 toxin by the CYP450 enzymes
and a chemical inhibition method was used to study carboxylesterase metabolism. Samples incubated with human liver microsomes were analyzed by high performance liquid chromatography-triple quadrupole mass spectrometry (HPLC- QqQ MS) after a simple pretreatment.
Results:
2
In the presence of a carboxylesterase inhibitor
only 20% T-2 toxin was metabolized. When CYP enzyme inhibitors and a carboxylesterase inhibitor were both present
only 3% of the T-2 toxin was metabolized. The contributions of the CYP450 enzyme family to T-2 toxin metabolism followed the descending order CYP3A4
CYP2E1
CYP1A2
CYP2B6 or CYP2D6 or CYP2C19.
Conclusions:
2
Carboxylesterase and CYP450 enzymes are of great importance in T-2 toxin metabolism
in which carboxylesterase is predominant and CYP450 has a subordinate role. CYP3A4 is the principal member of the CYP450 enzyme family responsible for T-2 toxin metabolism. The metabolite produced by carboxylesterase is HT-2
and the metabolite produced by CYP 3A4 is 3’-OH T-2. The different metabolites show different toxicities. Our results will provide useful data concerning the toxic mechanism
the safety evaluation
and the health risk assessment of T-2 toxin.
Li Y , Wang Z , Beier RC , Shen J , De Smet D , De Saeger S , et al . T-2 toxin, a trichothecene mycotoxin: review of toxicity, metabolism, and analytical methods . J Agric Food Chem . 2011 ; 59 : 3441 - 53 .
World Health Organization . Selected mycotoxins: ochratoxins, trichothecenes, ergot (environmental health criteria 105) . Geneva : WHO ; 1990 . p. 92 - 3 .
Visconti A , Minervini F , Lucivero G , Gambatesa V . Cytotoxic and immunotoxic effects of Fusarium mycotoxins using a rapid colorimetric bioassay . Mycopathologia . 1991 ; 113 : 181 - 6 .
Yagen B , Bialer M . Metabolism and pharmacokinetics of T-2 toxin and related trichothecenes . Drug Metab Rev . 1993 ; 25 : 281 - 323 .
Sintov A . Pharmacokinetics and protein binding of trichothecene mycotoxins T-2 toxin and HT-2 toxin in dogs . Toxicon . 1988 ; 26 : 153 - 60 .
Busman M , Poling SM , Maragos CM . Observation of T-2 toxin and HT-2 toxin glucosides from Fusarium sporotrichioides by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) . Toxins . 2011 ; 2 : 1554 - 8 .
Yoshizawa T , Sakamoto T , Kuwamura K . Structures of deepoxytrichothecene metabolites from 3'-hydroxy HT-2 toxin and T-2 tetraol in rats . Appl Environ Microbiol . 1985 ; 50 : 676 - 9 .
Izzo AA , Ernst E . Interactions between herbal medicines and prescribed drugs: an updated systematic review . Drugs . 2009 ; 69 : 1777 - 98 .
Scott EE , Halpert JR . Structures of cytochrome P450 3A4 . Trends Biochem Sci . 2005 ; 30 : 5 - 7 .
Meissonnier GM , Laffitte J , Raymond I , Benoit E , Cossalter AM , Pinton P , et al . Subclinical doses of T-2 toxin impair acquired immune response and liver cytochrome P450 in pigs . Toxicology . 2008 ; 247 : 46 - 54 .
Osselaere A , Li SJ , De Bock L , Devreese M , Goossens J , Vandenbroucke V , et al . Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens . Food Chem Toxicol . 2013 ; 55 : 150 - 5 .
Xie G , Zhou DY , Cheng KW , Wong CC , Rigas B . Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans . Biochem Pharmacol . 2013 ; 85 : 1195 - 202 .
Cacciatore LC , Guerrero NV , Cochon AC . Cholincarboxylesterase and carboxylesterase inhibition in Planorbarius corneus exposed to binary mixtures of azinphos-methyl and chlorpyrifos . Aqua Toxicol . 2013 ; 128 : 124 - 34 .
Johnsen H , Odden E , Lie O , Johnsen BA , Fonnum F . Metabolism of T-2 toxin by rat liver carboxylesterase . Biochem Pharmacol . 1986 ; 35 : 1469 - 73 .
Zhang D , Zhu M , Humphreys WG . Drug metabolism in drug design and development: basic concepts and practice . Wiley-Interscience ; 2008 . p. 477 - 512 .
Zhao Y , Lin N , Guo L , Chen J , Liu W , Xie J . Simultaneous determination of T-2 toxin and its metabolites in rat plasma using solid phase extraction and ultra performance liquid chromatography-tandem mass spectrometry . Chin J Anal Chem . 2012 ; 40 : 1852 - 8 .
Obach RS , Reed-Hagen AE . Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach . Drug Metab Dispos . 2002 ; 30 : 831 - 7 .
Fowler S , Zhang HJ . In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodlogies and their utility for predicting drug-drug interactions . AAPS J . 2008 ; 10 : 410 - 24 .
US FDA . Drug Interaction Studies -Study Design, Data Analysis, and Implications for Dosing and Labeling [EB/OL][A] . Guidance for Industry 2010 . 2010 . http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072101.pdf http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072101.pdf
Inoue S , Howgate EM , Rowland-Yeo K , Shimada T , Yamazaki H , Tucker GT , et al . Prediction of in vivo drug clearance from in vitro data. Ⅱ: potenzial inter-ethnic differences . Xenobiotica . 2006 ; 36 : 499 - 513 .
Rodrigues AD . Intergrated cytochrome P450 reaction phenotyping. Attempting to bridge the gap between cDNA expressed cytchromesP450 and native human liver microsomes . Biochem Pharmacol . 1999 ; 57 : 465 - 80 .
Wang J , Jiang J , Zhang H , Wang J , Cai H , Li C , et al . Integrated transcriptional and proteomic analysis with in vitro biochemical assay reveal the important role of CYP3A46 in T-2 toxin hydroxylation in porcine primary hepatocytes . Mol Cell Proteomics . 2011 ; 10 : M111.008748 .
Thummel KE , Wilkinson GR . In vitro and in vivo drug interactions involving human CYP3A . Annu Rev Pharmacol Toxicol . 1998 ; 38 : 389 - 430 .
Ge X , Wang J , Liu J , Jiang J , Lin H , Wu J , et al . The catalytic activity of cytochrome P450 3A22 is critical for the metabolism of T-2 toxin in porcine reservoirs . Catalysis Communications . 2010 ; 12 : 71 - 5 .
Shang S , Jiang J , Deng Y . Chicken cytochrome P450 1A5 is the key enzyme for metabolizing T-2 toxin to 3'OH-T-2 . Int J Mol Sci . 2013 ; 14 : 10809 - 18 .
Yuan Y , Zhou X , Yang J , Li M , Qiu X . T-2 toxin is hydroxylated by chicken CYP3A37 . Food Chem Toxicol . 2013 ; 62 : 622 - 7 .
0
浏览量
0
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621